Zobrazeno 1 - 10
of 26
pro vyhledávání: '"JoRean D. Sicks"'
Autor:
Brett M. Goshe, Autumn W. Rasmussen, Lynne I. Wagner, JoRean D. Sicks, Ilana F. Gareen, Ruth C. Carlos, Benjamin A. Herman, Angela Wangari Walter, Susan Regan, Douglas E. Levy, Irene Mahon, Alona Muzikansky, Jordan M. Neil, Michelle Lui, Deepika Dilip, Laura Malloy, Irina Gonzalez, Lucy Finkelstein-Fox, Caitlin McCann, Elissa Perez, Jamie S. Ostroff, Elyse R. Park
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Persistent smoking among patients diagnosed with cancer is associated with adverse clinical outcomes, yet an evidence-based tobacco use intervention has not been well-integrated into cancer care in community oncology settings. Thi
Externí odkaz:
https://doaj.org/article/90016e3cc7244a6c97f0c19fa398cccb
Autor:
Brendan C. Stack, Fenghai Duan, Justin Romanoff, JoRean D. Sicks, Rathan M. Subramaniam, Val J. Lowe
Publikováno v:
Clin Nucl Med
FDG PET/CT was prospectively studied in 287 cN0 head and neck cancer patients in ACRIN 6685, and additional analysis of neck FDG uptake upon recurrence-free survival (RFS) and overall survival (OS) was performed.Two hundred eight had analyzable data.
Autor:
Val J. Lowe, Fenghai Duan, Jeremy D. Richmon, Brian Nussenbaum, Justin Romanoff, David Cognetti, Jian Q. Michael Yu, JoRean D. Sicks, Charles D. Arnold, Twyla Bartel, Rathan M. Subramaniam, Brendan C. Stack
Publikováno v:
Journal of Clinical Oncology. 37:1704-1712
PURPOSE The objective of this study was to determine the negative predictive value (NPV) of positron emission tomography (PET)/computed tomography (CT) for the clinically N0 neck on the basis of neck dissection. METHODS Participants with newly diagno
Autor:
Caroline Chiles, Kathryn E. Weaver, JoRean D. Sicks, Charles Kamen, Lucy Gansauer, Anne E. Kazak, Joseph M. Unger, Ruth C. Carlos, Heather B. Neuman
Publikováno v:
Journal of the American College of Radiology. 16:427-434
Purpose Annual low-dose CT (LDCT) for lung screening in high-risk individuals decreases both lung cancer–specific mortality and all-cause mortality. Community oncology practice networks constituting the National Cancer Institute Community Oncology
Autor:
Anna N.A. Tosteson, JoRean D. Sicks, Qianfei Wang, Tor D. Tosteson, Ilana F. Gareen, William C Black
Publikováno v:
Medical Care. 56:403-409
BACKGROUND The National Lung Screening Trial (NLST) reported lung cancer and all-cause mortality reductions for low-dose computed tomography (LDCT) versus chest x-ray (CXR) screening. Although LDCT lung screening has received a grade B from the Unite
Autor:
Lynne I. Wagner, Fenghai Duan, Ilana F. Gareen, Ruth C. Carlos, Paul Tracy Mehan, Sheetal Mehta Kircher, Heather Kehn, Ellen Underwood, Jared David Acoba, JoRean D. Sicks, Michael A Taylor, Jennifer Marie Suga
Publikováno v:
Journal of Clinical Oncology. 39:1518-1518
1518 Background: Cancer therapy costs continue to rise, resulting in FB. FB in CRC treated with curative intent remains unexplored, particularly in the community oncology setting. We assess baseline FB and 3-month change, including predictors. Method
Autor:
Gary I. Cohen, Emily V. Dressler, Thomas E. Lad, Julia R. Trosman, Bill Stanfield, Lynne I. Wagner, Judith O. Hopkins, Ruth C. Carlos, Preston D. Steen, Heather Kehn, JoRean D. Sicks, Gregory J. Tsongalis, Kathryn E. Weaver, Bruce D. Rapkin, Judy Hancock, Christine B. Weldon
Publikováno v:
Journal of Clinical Oncology. 39:e18649-e18649
e18649 Background: Molecular biomarker testing is integral to NSCLC cancer care, but adoption and testing practices in the community are varied and often suboptimal. Testing practices, such as standard testing protocols and results turnaround time (T
Autor:
Heather M. Rozjabek, Ilana F. Gareen, Anthony B. Miller, Kathy L. Clingan, Pamela M. Marcus, Vincent P. Doria-Rose, JoRean D. Sicks, Brenda K. Brewer, Kristen Keating, Jennifer Rosenbaum, Joshua M. Rathmell
Publikováno v:
Clinical Trials. 13:434-438
Background/aims: Randomized controlled trials frequently use death review committees to assign a cause of death rather than relying on cause of death information from death certificates. The National Lung Screening Trial, a randomized controlled tria
Autor:
Pallavi Kumar, Christopher S. Lathan, Ilana F. Gareen, Elyse R. Park, Giselle K. Perez, JoRean D. Sicks, Kelly A. Hyland
Publikováno v:
The Oncologist. 21:40-49
Background. Black smokers have demonstrated greater lung cancer disease burden and poorer smoking cessation outcomes compared with whites. Lung cancer screening represents a unique opportunity to promote cessation among smokers; however, little is kn
Autor:
Pallavi Kumar, Ilana F. Gareen, Alaina Carr, JoRean D. Sicks, Giselle K. Perez, Kelly A. Hyland, Elyse R. Park, Christopher S. Lathan, Colin Ponzani
Publikováno v:
J Racial Ethn Health Disparities
Previous work suggests that, compared to white adults, black adults have lower perceived risk for smoking-related diseases (SRDs), which may influence cessation behavior and health outcomes; however, racial differences in SRD risk perceptions among h